Relevant bibliographies by topics / Adverse events reporting

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Adverse events reporting'

Author: Grafiati
Published: 26 July 2021
Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Adverse events reporting.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Adverse events reporting"

1

Higuchi, K. "Adverse Events Reporting." Clinical Drug Investigation 27, no. 3 (2007): 225. http://dx.doi.org/10.2165/00044011-200727030-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Leape, Lucian L. "Reporting of Adverse Events." New England Journal of Medicine 347, no. 20 (2002): 1633–38. http://dx.doi.org/10.1056/nejmnejmhpr011493.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Feagins, Linda A., George G. Abdelsayed, and Jason Schairer. "Reporting Adverse Drug Events." American Journal of Gastroenterology 114, no. 9 (2019): 1411–13. http://dx.doi.org/10.14309/ajg.0000000000000374.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Davis, Giles. "Reporting suspected adverse events." Veterinary Record 174, no. 1 (2014): 21.2–22. http://dx.doi.org/10.1136/vr.f7637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cano, Steven B., Kate Farthing, Aryeh Hurwitz, et al. "Reporting On Adverse Clinical Events." Clin-Alert 38, no. 3 (2000): 1–8. http://dx.doi.org/10.1177/006947700003800301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cano, Steven B., Kate Farthing, Aryeh Hurwitz, et al. "Reporting On Adverse Clinical Events." Clin-Alert 39, no. 1 (2001): 1–8. http://dx.doi.org/10.1177/006947700103900101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Generali, Joyce, Anne Le, and Erin Wilhite. "Reporting on Adverse Clinical Events." Clin-Alert 42, no. 7 (2004): 1–8. http://dx.doi.org/10.1177/0069477004265921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Culley, Colleen, Kate Farthing, Aryeh Hurwitz, et al. "Reporting on Adverse Clinical Events." Clin-Alert 42, no. 12 (2004): 1–14. http://dx.doi.org/10.1177/0069477004268139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Culley, Colleen, Kate Farthing, Daniel Hinthorn, William N. Kelly, Sondra May, and Jacyntha Sterling. "Reporting on Adverse Clinical Events." Clin-Alert 45, no. 8 (2007): 1–8. http://dx.doi.org/10.1177/0069477007303173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Culley, Colleen, Kate Farthing, Daniel Hinthorn, William N. Kelly, and Jacyntha Sterling. "Reporting on Adverse Clinical Events." Clin-Alert 45, no. 9 (2007): 1–8. http://dx.doi.org/10.1177/0069477007303871.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Adverse events reporting"

1

Zeeshan, Muhammad Fazal. "Use of an Electronic Reporting System to Determine Adverse Event Rates, Adverse Event Costs, and the Relationship of Adverse Events with Patients’ Body Mass Index." The Ohio State University, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=osu1372765526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Patel, Rachna. "Pharmacists’ Attitudes towards Reporting Adverse Drug Events in the United Kingdom." The University of Arizona, 2009. http://hdl.handle.net/10150/623981.

Full text
Abstract:
Class of 2009 Abstract<br>OBJECTIVES: To determine the likelihood of pharmacists in England of reporting adverse drug reactions (ADR), whether they are aware of the reporting processes, and what they believe the reasons for not reporting may be. METHODS: A survey containing five different scenarios of ADRs was distributed to licensed, community pharmacists around Surrey, England. The responses were analyzed using rates and chi-square. RESULTS: A total of 47 surveys were returned to the researcher. Of those, 72% of the participants were likely to report the adverse drug reaction in the scenar
APA, Harvard, Vancouver, ISO, and other styles
3

Leeder, Ciera. "Epidemiology of Patient Safety Events in an Academic Teaching Hospital." Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/34294.

Full text
Abstract:
Background: Adverse events are poor health outcomes caused by medical care rather than the underlying disease process. Voluntary reporting is a key component to adverse event reduction; however, incident reporting systems contain many limitations. The Patient Safety Learning System (PSLS) is an electronic incident reporting system with several unique features that were designed to address the weaknesses of previous systems, including a process for physician assessment of reported events to determine their significance. The primary objectives for this study were to determine the positive pre
APA, Harvard, Vancouver, ISO, and other styles
4

Yenyi, Samuel Errie. "Influence of Low Rate of Reporting of Adverse Events Following Immunization on Immunization Dropout." ScholarWorks, 2019. https://scholarworks.waldenu.edu/dissertations/6709.

Full text
Abstract:
Immunization protects millions of children. Yet, many children drop out of immunization in Jigawa State of north Nigeria. This cross-sectional quantitative correlational study based on the Health Belief Model was designed to determine whether the dropout from routine immunization (RI) was influenced by low rate of reporting of adverse events following immunization (AEFI) to health facilities by caregivers. Primary data was collected from 307 caregivers with dropout children using structured interviewer-administered questionnaire. The data were analyzed using logistic regression and descriptive
APA, Harvard, Vancouver, ISO, and other styles
5

Bezerra, Milena Pontes Portela. "Study of adverse events in an accredited secondary hospital of CearÃ: an approach to risk management." Universidade Federal do CearÃ, 2011. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=7401.

Full text
Abstract:
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior<br>Study of adverse events in an accredited secondary hospital of CearÃ: an approach to risk management. Author: Milena Pontes Portela Beserra. Supervisor: ProfÂ. Dr Marta Maria de FranÃa Fonteles. [Master degreeâs dissertation. Post Graduation in Pharmaceutical Science. Department of Pharmacy â Federal University of CearÃ]. BACKGROUND: Hospital Risk Management acts in the prevention, detection, control or eliminate risks that could cause harm to patients, in Brazil this concept was implemented in 2001 by the National Agency for Sani
APA, Harvard, Vancouver, ISO, and other styles
6

Lamb, James Alexander. "Under-reporting of Adverse Drug Reactions to the Food & Drug Administration." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/6055.

Full text
Abstract:
This study examined the potential significant differences in the distribution of adverse drug reactions (ADRs) by reporter (consumer versus physician) and patient outcome at case and event level. This study also contains exploratory questions to evaluate reporting of ADRs by consumers versus physician by system organ class (SOC) and reporter demographics within the United States Food & Drug Administration Adverse Event Reporting System (FAERS). The theoretical foundation applied in this quantitative study was the social amplification of risk framework. Data from the second quarter of 2016 were
APA, Harvard, Vancouver, ISO, and other styles
7

Leitão, Ana Lúcia Pedrosa. "Notificação de incidentes e eventos adversos em neonatologia : adaptação de um sistema de notificação numa unidade de cuidados intermédios neonatal." Master's thesis, Universidade Nova de Lisboa. Escola Nacional de Saúde Pública, 2011. http://hdl.handle.net/10362/9422.

Full text
Abstract:
RESUMO - A segurança do doente é um tema que tem sido amplamente estudado por todo o mundo. Com o desenvolvimento do conhecimento, das técnicas e o advento das learning organizations é possível detectar as áreas onde existe potencial risco, conhecer o número de incidentes de forma sistemática, promover a evolução das técnicas nas áreas mais urgentes, determinar o impacto de todos os incidentes e eventos adversos, aprender com eles e promover modificações nas organizações. A neonatologia não foi excepção, pelo que se pretende a criação e validação de um sistema de notificação de eventos advers
APA, Harvard, Vancouver, ISO, and other styles
8

Rozental, Alexander. "Negative effects of Internet-based cognitive behavior therapy : Monitoring and reporting deterioration and adverse and unwanted events." Doctoral thesis, Stockholms universitet, Klinisk psykologi, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-135382.

Full text
Abstract:
Internet-based cognitive behavior therapy (ICBT) has the potential of providing many patients with an effective form of psychological treatment. However, despite helping to improve mental health and well-being, far from everyone seem to benefit. In some cases, negative effects may also emerge. The overall aim of the present thesis was to establish the occurrence and characteristics of such incidents in ICBT using a combination of quantitative and qualitative methods. Study I determined deterioration, non-response, and adverse and unwanted events in a sample of 133 patients undergoing ICBT for
APA, Harvard, Vancouver, ISO, and other styles
9

Alhammad, Ali M. "FACTORS INFLUENCING PHARMACISTS’ DECISION TO REPORT ADVERSE EVENTS RELATED TO DIETARY SUPPLEMENTS." VCU Scholars Compass, 2012. http://scholarscompass.vcu.edu/etd/2849.

Full text
Abstract:
Background: The increasing consumption of dietary supplements (DS) has drawn the attention of regulatory agencies, researchers and healthcare professionals. The US Food and Drug Administration (FDA) does not require premarketing assessment of DS considering them safe unless proven otherwise. However, the reporting rate of DS adverse events (DS-AE) is low. Objective: To describe pharmacists’ attitudes and knowledge of DS and DS information resources, and to determine the importance of selected attributes in pharmacists’ decisions to report a DS-AE. Methods: A convenience sample of practicing ph
APA, Harvard, Vancouver, ISO, and other styles
10

Lima, Sara Silveira. "Sistema de notificação de eventos adversos : contributos para a melhoria da segurança do doente." Master's thesis, Universidade Nova de Lisboa. Escola Nacional de Saúde Pública, 2011. http://hdl.handle.net/10362/9417.

Full text
Abstract:
RESUMO - Este estudo insere-se na temática dos sistemas de notificação de eventos adversos. Pretende-se compreender a necessidade e importância de implementação de um sistema de notificação de Eventos Adversos num hospital E.P.E. (entidade pública empresarial) de Lisboa. Apresenta como objectivo geral: •Identificar as principais características que um Sistema de Notificação de Eventos Adversos, Erros e Incidentes deve ter e com base nisso propor um formulário de notificação que assente numa lógica de aprendizagem e não numa perspectiva de culpabilização. Trata-se de um estudo explorató
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Adverse events reporting"

1

Osman, Mansoor, ed. Immunization safety surveillance: Guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization. World Health Organization, Regional Office for the Western Pacific, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Health, Zambia Ministry of. Guidelines for detecting and reporting adverse drug or vaccine reactions and events in Zambia: The safety of medicines in Zambia : why health workers need to take action. National Pharmacovigilance Unit, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Saskatchewan. Joint Committee on Drug Utilization. Drug Adverse Event Reporting in Saskatchewan. s.n, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Health, Zambia Ministry of, and Pharmaceutical Regulatory Authority (Zambia). National Pharmacovigilance Unit., eds. Guidelines for detecting and reporting adverse drug or vaccine reactions and events in Zambia: The safety of medicines in Zambia : why health workers need to take action. National Pharmacovigilance Unit, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Health, Zambia Ministry of, and Pharmaceutical Regulatory Authority (Zambia). National Pharmacovigilance Unit., eds. Guidelines for detecting and reporting adverse drug or vaccine reactions and events in Zambia: The safety of medicines in Zambia : why health workers need to take action. National Pharmacovigilance Unit, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Megan, Beckett, ed. A review of current state-level adverse medical event reporting practices: Toward national standards. RAND Corporation, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1946-, Drazen Jeffrey M., Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation., and Institute of Medicine (U.S.). Board on Health Sciences Policy., eds. Adverse drug event reporting: The roles of consumers and health-care professionals : workshop summary. National Academies Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brown, Michael A. A history of a cGMP medical event investigation. John Wiley & Sons, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ray, Sumantra (Shumone), Sue Fitzpatrick, Rajna Golubic, Susan Fisher, and Sarah Gibbings, eds. Safety reporting. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199608478.003.0019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Albrecht, Douglas. Guide to Reporting and Data Mangement of Adverse Events Involving Medical Devices. Wiley & Sons, Incorporated, John, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Adverse events reporting"

1

Friedman, Lawrence M., Curt D. Furberg, and David L. DeMets. "Assessing and Reporting Adverse Events." In Fundamentals of Clinical Trials. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1586-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Senior, Hugh. "Assessing and Reporting Adverse Events." In The Essential Guide to N-of-1 Trials in Health. Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-017-7200-6_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sanchez, Juan A., and Paul Barach. "Capturing, Reporting, and Learning from Adverse Events." In Surgical Patient Care. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-44010-1_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lammers, M. W., and H. Meinardi. "On the Reporting of Adverse Drug Events." In Quantitative Assessment in Epilepsy Care. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2990-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

El Hechi, Majed, and Haytham M. A. Kaafarani. "Detecting and Reporting Errors, Complications, and Adverse Events." In Principles of Perioperative Safety and Efficiency. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-41089-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Huynh, Phuong, and Renza Monteleone. "Adverse Events and Corrective and Preventive Actions." In Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-64492-5_11.

Full text
Abstract:
AbstractEverything that is not compliant with SOP, guidelines, national and international standards, and legal requirements could affect the quality and safety of the cellular products and all processes. To guarantee the safety of cellular products, to protect recipients, donors, and personnel, it is necessary to have in place a robust system for reporting, investigating, and resolving all occurrences: errors, accidents, adverse events, biological product deviations, and complaints.In some case, the management of adverse events and other type of deviations is included in hospital management, b
APA, Harvard, Vancouver, ISO, and other styles
7

Åserød, Hanne, and Ankica Babic. "Designing a mobile system for safety reporting of arthroplasty adverse events." In EMBEC & NBC 2017. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-5122-7_143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yildirim, Pinar, Marcus Bloice, and Andreas Holzinger. "Knowledge Discovery and Visualization of Clusters for Erythromycin Related Adverse Events in the FDA Drug Adverse Event Reporting System." In Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43968-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Andersen, Henning Boje, Niels Hermann, Marlene D. Madsen, Doris Østergaard, and Thomas Schiøler. "Hospital Staff Attitudes to Models of Reporting Adverse Events: Implications for Legislation." In Probabilistic Safety Assessment and Management. Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-410-4_436.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Poploski, Kathleen M., Alexandra B. Gil, Charity G. Patterson, Volker Musahl, and James J. Irrgang. "Introduction to Surgical Trials: Adverse Events Reporting and Data and Safety Monitoring." In Introduction to Surgical Trials. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-77563-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Adverse events reporting"

1

Wang, Bo. "Analysis of FDA Adverse Event Reporting System Based on Toolformer." In 2024 IEEE Integrated STEM Education Conference (ISEC). IEEE, 2024. http://dx.doi.org/10.1109/isec61299.2024.10665011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Afolalu, Olamide O., Sunday A. Afolalu, Oladele F. Afolalu, and Oluwaseyi A. Akpor. "Internet of Things and Software Applications in Patient Safety Adverse Event Detection and Reporting: A Comprehensive Literature Review." In 2024 International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG). IEEE, 2024. http://dx.doi.org/10.1109/seb4sdg60871.2024.10629786.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Torres, Vanessa, and Filipa Carvalho. "Adverse Events in Dental Care: A Review Towards Notification." In 13th International Conference on Applied Human Factors and Ergonomics (AHFE 2022). AHFE International, 2022. http://dx.doi.org/10.54941/ahfe1002624.

Full text
Abstract:
The occurrence of adverse events (AE) in healthcare represents a severe problem for the quality of care, due to unsafe or poor quality of healthcare service. Similar to many other healthcare environments, Dentistry entails inherent patient safety risks. Research on patient safety has been developed over the last decades, however, it is important to consider AE to improve patient safety in this care environment, as adequate reporting systems for this area of intervention are not known. Thus, the main aim of this study was to carry out a literature review to investigate AE exclusively related to
APA, Harvard, Vancouver, ISO, and other styles
4

Pundole, X., M. Sarangdhar, and M. E. Suarez-Almazor. "OP0197 Rheumatic and musculoskeletal adverse events associated with immune checkpoint inhibitors: data mining of the us food and drug administration adverse event reporting system." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6113.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shen, Bairong, Li Chen, and Javier Meana. "Eye Disorders Associated with newer Antiepileptic drugs: A real-world disproportionality analysis of FDA Adverse Reporting System events." In MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed. MDPI, 2021. http://dx.doi.org/10.3390/mol2net-07-11616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Watyaba, Benjamin, Ivana Knezevic, Florence Adong, et al. "PA-364 Knowledge and reporting of adverse events following childhood immunization among health workers and caregivers at Mengo hospital, Kampala." In Abstracts of The Eleventh EDCTP Forum, 7–10 November 2023. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/bmjgh-2023-edc.171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Larrea Urtaran, X., A. Pérez Plasencia, M. Coma Punset, et al. "5PSQ-104 Voluntary electronic reporting of medication errors and adverse drugs events during the first year of the COVID-19 pandemic." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.320.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhou, Elsa S., and Sujata K. Bhatia. "Reported Device Failure and the Coronavirus Pandemic: Cardiovascular Interventions." In 2022 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2022. http://dx.doi.org/10.1115/dmd2022-1019.

Full text
Abstract:
Abstract Regular cardiology practices were interrupted by the COVID-19 pandemic. To better understand the pandemic’s effects on cardiology practices, we investigated whether the pandemic affected reporting of cardiovascular medical device failure by examining whether adverse event reports per week attributed to different cardiovascular devices changed significantly during the pandemic. By using data from FDA’s MAUDE database, we compared weekly rates of adverse event reports over the course of three years attributed to each of four devices: ‘Implantable Cardioverter Defibrillator (Non-CRT)’, ‘
APA, Harvard, Vancouver, ISO, and other styles
9

Soliman, Nada Hossam, Ahmed T. M. Aboughalia, Tawanda Chivese, et al. "A Meta-Review of Meta-Analyses and an Updated Meta-Analysis on the Efficacy of Chloroquine and Hydroxychloroquine in treating COVID-19 Infection." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0308.

Full text
Abstract:
Objective: To synthesize the findings presented in systematic reviews and meta-analyses as well as to update the evidence using a meta-analysis in evaluating the efficacy and safety of CQ and HCQ with or without Azithromycin for the treatment of COVID-19 infection. Methods: The design of this meta-review followed the preferred reporting items for overviews of systematic reviews including harms checklist (PRIO-harms). A comprehensive search included several electronic databases in identifying all systematic reviews and meta-analyses as well as experimental studies which investigated the efficac
APA, Harvard, Vancouver, ISO, and other styles
10

Carpinelli, Fabrizio, and Bart Accou. ""Stop investigating events": Combining in-depth and HOF driven analysis of work, as performed in the reality of day-to-day operations." In 15th International Conference on Applied Human Factors and Ergonomics (AHFE 2024). AHFE International, 2024. http://dx.doi.org/10.54941/ahfe1005302.

Full text
Abstract:
In high-risk industries, a lot of time and effort is invested in reporting and investigating accidents, incidents, and other types of events, to finally result – very often – in a collection of little useful information vis-à-vis explicit safety- and/or risk management. This leaves the loop of continuous improvement of the organisation of safety open, and similar events to happen again. With such an approach, the future of the safety management system (SMS) seems compromised.There are several reasons for this. The scope of the investigations is often limited to the immediate causes and operati
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Adverse events reporting"

1

Syrowatka, Ania, Aneesa Motala, Emily Lawson, and Paul Shekelle. Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepc_mhs4mederror.

Full text
Abstract:
Objectives. To assess the evidence on the effects of computerized clinical decision support systems (CDSSs) on the prevention of medication errors and adverse drug events, related implementation outcomes such as rates of medication alert overrides, and unintended consequences of use. We also summarized the literature around the effective implementation of a CDSS. Methods. We followed the rapid review processes of the Agency for Healthcare Research and Quality Evidence-based Practice Center Program. We queried PubMed and the Cochrane Library to locate relevant systematic reviews and primary stu
APA, Harvard, Vancouver, ISO, and other styles
2

Apiyo, Eric, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Improving Pharmacovigilliance Quality Management System in the Pharmacy and Poisions Board of Kenya. Purdue University, 2021. http://dx.doi.org/10.5703/1288284317444.

Full text
Abstract:
The purpose of this study was to explore ways of improving the pharmacovigilance quality system employed by the Pharmacy and Poisons Board of Kenya. The Pharmacy and Poisons Board of Kenya employs a hybrid system of pharmacovigilance that utilizes an online system of reporting pharmacovigilance incidences and a physical system, where a yellow book is physically filled by the healthcare worker and sent to the Pharmacy and Poisons Board for onward processing. This system, even though it has been relatively effective compared to other systems employed in Africa, has one major flaw. It is a slow a
APA, Harvard, Vancouver, ISO, and other styles
3

Robles, Marcelo, and Claudio Dachevsky. Evaluation of the efficacy and safety of cross-linked hyaluronic acid 30 mg/ml for filling nasolabial folds. Edited by María Fernanda Cristoforetti. Lugones Editorial, 2025. https://doi.org/10.47196/0590.

Full text
Abstract:
Introduction: the nasolabial folds (NLF) are a highly mobile facial region that undergoes multifactorial changes during aging. Cientific Hyaluronic Facial Implant 30® is a 30 mg/ml cross-linked hyaluronic acid (HRA) filler developed to optimize the results of this highly dynamic facial area. Objectives: to evaluate the safety and efficacy of Cientific Hyaluronic Facial Implant 30® (CH30), composed of 30 mg/ml HRA, for the correction of moderate to severe NLF. Materials and methods: a 12-month, prospective, multicenter clinical study that included 64 male and female patients between 30 and 75 y
APA, Harvard, Vancouver, ISO, and other styles
4

Selph, Shelley S., Andrea C. Skelly, Tracy Dana, et al. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents: A Systematic Review. Agency for Healthcare Research and Quality, 2025. https://doi.org/10.23970/ahrqepcsrdisruptive.

Full text
Abstract:
Objectives. To determine the most effective treatments for clinically significant disruptive behaviors in children and adolescents. Data sources. Ovid® MEDLINE®, the Cochrane Library, PsycINFO®, and Embase® databases were searched from 2014 to July 22, 2024. Additionally, we reviewed all studies included in the prior 2015 Agency for Healthcare Research and Quality review. Review methods. We dual reviewed abstracts and full-text articles; data extraction was checked by a second reviewer; risk of bias and strength of evidence were assessed by two reviewers; and disagreements were resolved by con
APA, Harvard, Vancouver, ISO, and other styles
5

Winters, Bradford D., Michael Rosen, Ritu Sharma, Allen Zhang, and Eric B. Bass. Failure To Rescue – Rapid Response Systems. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepc_mhs4rescue.

Full text
Abstract:
Objectives. Rapid response systems address unexpected and unrecognized clinical deterioration on general hospital wards and aim to prevent cardiorespiratory arrests. These systems have an afferent limb (recognition and activation) and an efferent limb (response). Our main objectives were to determine the effectiveness of rapid response systems on patient safety and clinical outcomes and how rapid response systems can be implemented effectively. Methods. We searched PubMed and the Cochrane library for eligible systematic reviews and primary studies published from January 2018 through June 2023,
APA, Harvard, Vancouver, ISO, and other styles
6

Winters, Bradford D. Patient Monitoring Systems To Prevent Failure To Rescue. Agency for Healthcare Research and Quality (AHRQ), 2024. https://doi.org/10.23970/ahrqepc_mhs4monitoring.

Full text
Abstract:
Objectives. To review the evidence published after the previous Making Healthcare Safer (MHS) report on the effectiveness of implementing patient monitoring systems that scan patient data for signs of clinical deterioration to alert a clinician of a potential adverse condition. Methods. We searched PubMed and the Cochrane library for systematic reviews and primary studies, published from January 2018 to April 2024, of patient monitoring systems reporting the activation of a rapid response system (RRS), incidence of cardiorespiratory arrest, hospital mortality, transition to higher level of car
APA, Harvard, Vancouver, ISO, and other styles
7

E, Flemyng, and Mitchell D. Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children: Protocol. Epistemonikos Interactive Evidence Synthesis, 2022. http://dx.doi.org/10.30846/ies.b984bf9656.v3.

Full text
Abstract:
Abstract Rationale Early treatment of asthma exacerbations with inhaled corticosteroids is the best strategy for management, although use of an increased or stable dose is questioned. Objectives To compare the clinical effectiveness and safety of increased versus stable doses of inhaled corticosteroids as part of a patient-initiated action plan for the home management of exacerbations in children and adults with persistent asthma. Search methods We searched the Cochrane Airways Group Specialised Register (part of CENTRAL), MEDLINE, Embase, CINAHL, major trials registries and handsearched abstr
APA, Harvard, Vancouver, ISO, and other styles
8

E, Flemyng, and Mitchell D. Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children: Protocol. Epistemonikos Interactive Evidence Synthesis, 2022. http://dx.doi.org/10.30846/ies.b984bf9699.v2.

Full text
Abstract:
Abstract Rationale Early treatment of asthma exacerbations with inhaled corticosteroids is the best strategy for management, although use of an increased or stable dose is questioned. Objectives To compare the clinical effectiveness and safety of increased versus stable doses of inhaled corticosteroids as part of a patient-initiated action plan for the home management of exacerbations in children and adults with persistent asthma. Search methods We searched the Cochrane Airways Group Specialised Register (part of CENTRAL), MEDLINE, Embase, CINAHL, major trials registries and handsearched abstr
APA, Harvard, Vancouver, ISO, and other styles
9

E, Flemyng, and Mitchell D. Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children: Update. Epistemonikos Interactive Evidence Synthesis, 2022. http://dx.doi.org/10.30846/ies.b984bf9639.v2.

Full text
Abstract:
Abstract Rationale Early treatment of asthma exacerbations with inhaled corticosteroids is the best strategy for management, although use of an increased or stable dose is questioned. Objectives To compare the clinical effectiveness and safety of increased versus stable doses of inhaled corticosteroids as part of a patient-initiated action plan for the home management of exacerbations in children and adults with persistent asthma. Search methods We searched the Cochrane Airways Group Specialised Register (part of CENTRAL), MEDLINE, Embase, CINAHL, major trials registries and handsearched abstr
APA, Harvard, Vancouver, ISO, and other styles
10

E, Flemyng, and Mitchell D. Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children: Protocol. Epistemonikos Interactive Evidence Synthesis, 2022. http://dx.doi.org/10.30846/ies.b984bf9656.v2.

Full text
Abstract:
Abstract Rationale Early treatment of asthma exacerbations with inhaled corticosteroids is the best strategy for management, although use of an increased or stable dose is questioned. Objectives To compare the clinical effectiveness and safety of increased versus stable doses of inhaled corticosteroids as part of a patient-initiated action plan for the home management of exacerbations in children and adults with persistent asthma. Search methods We searched the Cochrane Airways Group Specialised Register (part of CENTRAL), MEDLINE, Embase, CINAHL, major trials registries and handsearched abstr
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Adverse events reporting' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography